We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

16 hedge funds and large institutions have $624K invested in Dare Bioscience in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

14% more funds holding

Funds holding: 14 → 16 (+2)

0.29% less ownership

Funds ownership: 5.12% → 4.83% (-0.29%)

84% less capital inflows, than outflows

Capital inflows: $7.67K | Capital outflows: $46.9K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$3.44K
2
Victory Capital Management
Victory Capital Management
Texas
+$2.06K
3
Bank of America
Bank of America
North Carolina
+$1.38K
4
Wells Fargo
Wells Fargo
California
+$794

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$25.4K
2
Virtu Financial
Virtu Financial
New York
-$16K
3
Renaissance Technologies
Renaissance Technologies
New York
-$5.45K

DARE Hedge Fund Activity: Q3 2019 in Review

16 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q3 2019, worth a combined $624K — down 14% from $726K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new DARE positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Deutsche Bank, opening a new position worth an estimated $3.44K. The largest seller was Susquehanna International Group, cutting an estimated $25.4K.

  • 16 institutional investors held Dare Bioscience (DARE) as of Q3 2019, up from 14 in Q2 2019.
  • Funds reported $624K of Dare Bioscience stock for Q3 2019, down 14% quarter-over-quarter.
  • 4 funds opened new Dare Bioscience positions in Q3 2019 and 2 closed out, a net change of +2 holders.
  • The largest Dare Bioscience buyer in Q3 2019 was Deutsche Bank, an estimated $3.44K added.
  • The largest Dare Bioscience seller in Q3 2019 was Susquehanna International Group, an estimated $25.4K sold.

Based on aggregated 13F filings for Q3 2019.